Cardiac tumors other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(11 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cardiac tumors}}
{{Cardiac tumors}}
{{CMG}}; {{AE}} {{DMakkar}}


__NOTOC__
==Overview==
{{CMG}}; {{AE}} {{Dj}}
Cardiac Biopsy is recommended for the detection of specific cardiac tumors if the potential advantages outweigh the dangers. Quick histological identification permits prompt initiation of the right treatment. Cardiac Biopsy should be conducted by an experienced operator using fluoroscopy and transthoracic, transesophageal, or intracardiac echocardiography guidance to assure patient safety.


==Overview==
==Cardiac Tumors Biopsy Findings==
==Cardiac Tumors Biopsy Findings==
: Biopsy findings associated with cardiac tumors include the following:
: Biopsy findings associated with cardiac tumors include the following:
Line 15: Line 15:
| '''[[Myxoma]]''' || Hemorrhages, spindle or stellate cells, pseudovascular structure, myxoid matrix.
| '''[[Myxoma]]''' || Hemorrhages, spindle or stellate cells, pseudovascular structure, myxoid matrix.
*There may be dystrophic calcification present.
*There may be dystrophic calcification present.
*Immunohistochemical examination of PRKAR1A is a promising screening method for determining if myxomas form in Carney complex lesions.<ref name="pmid24618615">{{cite journal| author=Maleszewski JJ, Larsen BT, Kip NS, Castonguay MC, Edwards WD, Carney JA | display-authors=etal| title=PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors. | journal=Am J Surg Pathol | year= 2014 | volume= 38 | issue= 8 | pages= 1079-87 | pmid=24618615 | doi=10.1097/PAS.0000000000000202 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24618615  }} </ref>
|-
|-
|'''[[Cardiac Lipoma]]''' || Histopathologically, a cardiac lipoma is constituted of  
|'''[[Cardiac Lipoma]]''' || Histopathologically, a cardiac lipoma is constituted of  
*mature fat cells, fibrous connective tissue, and  
*mature fat cells, fibrous connective tissue, and  
*vacuolated brown fat.
*vacuolated brown fat.<ref name="pmid28436488">{{cite journal| author=Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW| title=Pathology, imaging, and treatment of cardiac tumours. | journal=Nat Rev Cardiol | year= 2017 | volume= 14 | issue= 9 | pages= 536-549 | pmid=28436488 | doi=10.1038/nrcardio.2017.47 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28436488  }} </ref>
|-
|-
|'''[[Cardiac Fibroma]]''' || Histologically, fibromas are predominantly made of  
|'''[[Cardiac Fibroma]]''' || Histologically, fibromas are predominantly made of:
*fibroblasts or collagen, with the characteristic "spindle cells."  
*Fibroblasts or collagen, with the characteristic "spindle cells."  
*Calcification of fibromas is especially prevalent among elderly people
*Calcification of fibromas is especially prevalent among elderly people.<ref name="pmid22447042">{{cite journal| author=Lamba G, Frishman WH| title=Cardiac and pericardial tumors. | journal=Cardiol Rev | year= 2012 | volume= 20 | issue= 5 | pages= 237-52 | pmid=22447042 | doi=10.1097/CRD.0b013e31825603e7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22447042 }} </ref>
|-
|'''[[Fibroelastoma]]''' ||  Histopathologically, a cardiac lipoma is constituted of
*endocardium-coated fronds contain an avascular collagenous core.
|-
|-
| '''[[Rhabdomyoma]]''' || Cardiac rhabdomyomas are characterized by  
| '''[[Rhabdomyoma]]''' || Cardiac rhabdomyomas are characterized by  
*classic spider cells, polygonal myocytes with conspicuous sarcoplasmic clearing.  
*classic spider cells, polygonal myocytes with conspicuous sarcoplasmic clearing.  
*Rhabdomyomas are formed of enlarged, vacuolated cardiomyocytes.  
*Rhabdomyomas are formed of enlarged, vacuolated cardiomyocytes.<ref name="pmid9424072">{{cite journal| author=Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM| title=Pediatric primary benign cardiac tumors: a 15-year review. | journal=Am Heart J | year= 1997 | volume= 134 | issue= 6 | pages= 1107-14 | pmid=9424072 | doi=10.1016/s0002-8703(97)70032-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9424072  }} </ref>
|-
|-
| '''[[Fibroelastomas]]''' ||  
| '''[[Fibroelastomas]]''' ||  
Line 41: Line 39:
*The lesions are packed by a mucoid  material and are bordered by epithelium, cytokeratin, and epithelial membrane antigen positive.<ref name="pmid15486108">{{cite journal| author=Moorjani N, Kuo J, Wilkins D| title=Left atrial phaeochromocytoma. | journal=Heart | year= 2004 | volume= 90 | issue= 11 | pages= e64 | pmid=15486108 | doi=10.1136/hrt.2004.041319 | pmc=1768537 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15486108  }} </ref>
*The lesions are packed by a mucoid  material and are bordered by epithelium, cytokeratin, and epithelial membrane antigen positive.<ref name="pmid15486108">{{cite journal| author=Moorjani N, Kuo J, Wilkins D| title=Left atrial phaeochromocytoma. | journal=Heart | year= 2004 | volume= 90 | issue= 11 | pages= e64 | pmid=15486108 | doi=10.1136/hrt.2004.041319 | pmc=1768537 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15486108  }} </ref>
|-
|-
|'''[[Hemangioma]]'''||  histologically characterized  
|'''[[Hemangioma]]'''||  Histologically characterized by:
*by small capillaries (capillary hemangioma), big vessels (cavernous hemangioma, the most frequent kind), or dysplastic vessels (cirsoid aneurysm).
*small capillaries (capillary hemangioma), big vessels (cavernous hemangioma, the most frequent kind), or dysplastic vessels (cirsoid aneurysm).<ref name="pmid28436488">{{cite journal| author=Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW| title=Pathology, imaging, and treatment of cardiac tumours. | journal=Nat Rev Cardiol | year= 2017 | volume= 14 | issue= 9 | pages= 536-549 | pmid=28436488 | doi=10.1038/nrcardio.2017.47 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28436488  }} </ref>
|-
|-
|'''[[Hamartoma of Cardiac Myocytes]]''' || Lesions are defined histologically by a  
|'''[[Hamartoma of Cardiac Myocytes]]''' || Lesions are defined histologically by a  
*nodular cluster of enlarged, highly disordered cardiomyocytes.<ref name="pmid18455585">{{cite journal| author=ElBardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ | display-authors=etal| title=Analysis of benign ventricular tumors: long-term outcome after resection. | journal=J Thorac Cardiovasc Surg | year= 2008 | volume= 135 | issue= 5 | pages= 1061-8 | pmid=18455585 | doi=10.1016/j.jtcvs.2007.10.048 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18455585  }} </ref>
*nodular cluster of enlarged, highly disordered cardiomyocytes.<ref name="pmid18455585">{{cite journal| author=ElBardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ | display-authors=etal| title=Analysis of benign ventricular tumors: long-term outcome after resection. | journal=J Thorac Cardiovasc Surg | year= 2008 | volume= 135 | issue= 5 | pages= 1061-8 | pmid=18455585 | doi=10.1016/j.jtcvs.2007.10.048 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18455585  }} </ref>
|-
|'''[[Undifferentiated Pleomorphic Sarcoma]]''' || Histopathologic features of Undifferentiated Pleomorphic Sarcoma are
*Typical spindle and polygonal (strap-like) cells filled with an eosinophilic cytoplasm
*Desmin- and myoglobin-positive
*CD68 negative<ref name="pmid14745155">{{cite journal| author=Nakagawa Y, Ikeda U, Hirose M, Ubukata S, Katsuki TA, Kaminishi Y | display-authors=etal| title=Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab). | journal=Circ J | year= 2004 | volume= 68 | issue= 2 | pages= 172-3 | pmid=14745155 | doi=10.1253/circj.68.172 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14745155  }} </ref>
|-
|'''[[Angiosarcoma]]''' || Microscopically, angiosarcomas are composed of:
*Actively growing, invading anaplastic cells originating from blood vessels and lining irregular blood-filled areas and malignant vascular tissue.
*There are typically extensive areas of bleeding and necrosis inside the tumor.<ref name="pmid28436488">{{cite journal| author=Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW| title=Pathology, imaging, and treatment of cardiac tumours. | journal=Nat Rev Cardiol | year= 2017 | volume= 14 | issue= 9 | pages= 536-549 | pmid=28436488 | doi=10.1038/nrcardio.2017.47 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28436488  }} </ref>
|}
|}


Line 54: Line 61:
{{WS}}
{{WS}}


[[Category:Needs content]]
[[Category:needs english review]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 20:21, 4 July 2022

Cardiac tumors Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Tumors from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac tumors other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac tumors other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac tumors other diagnostic studies

CDC on Cardiac tumors other diagnostic studies

Cardiac tumors other diagnostic studies in the news

Blogs on Cardiac tumors other diagnostic studies

Directions to Hospitals Treating Cardiac tumors

Risk calculators and risk factors for Cardiac tumors other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dheeraj Makkar, M.D.[2]

Overview

Cardiac Biopsy is recommended for the detection of specific cardiac tumors if the potential advantages outweigh the dangers. Quick histological identification permits prompt initiation of the right treatment. Cardiac Biopsy should be conducted by an experienced operator using fluoroscopy and transthoracic, transesophageal, or intracardiac echocardiography guidance to assure patient safety.

Cardiac Tumors Biopsy Findings

Biopsy findings associated with cardiac tumors include the following:
Cardiac Tumors Biopsy Findings
Tumor Biopsy Findings
Myxoma Hemorrhages, spindle or stellate cells, pseudovascular structure, myxoid matrix.
  • There may be dystrophic calcification present.
  • Immunohistochemical examination of PRKAR1A is a promising screening method for determining if myxomas form in Carney complex lesions.[1]
Cardiac Lipoma Histopathologically, a cardiac lipoma is constituted of
  • mature fat cells, fibrous connective tissue, and
  • vacuolated brown fat.[2]
Cardiac Fibroma Histologically, fibromas are predominantly made of:
  • Fibroblasts or collagen, with the characteristic "spindle cells."
  • Calcification of fibromas is especially prevalent among elderly people.[3]
Rhabdomyoma Cardiac rhabdomyomas are characterized by
  • classic spider cells, polygonal myocytes with conspicuous sarcoplasmic clearing.
  • Rhabdomyomas are formed of enlarged, vacuolated cardiomyocytes.[4]
Fibroelastomas
  • It consists of endocardium-coated fronds surrounding an avascular collagenous core.[2]
Mesothelioma Histopathology Mesothelioma cells can exhibit three different configurations,
  • namely largely epithelial, mostly fibrous (spindle cell), and biphasic (mixed).
  • Carcinoembryonic antigen (CEA) and positive mesothelial markers (calretinin and cytokeratins) may effectively distinguish mesotheliomas from pericardial metastases of adenocarcinoma.[5]
Cystic Tumor of the Atrioventricular Node The tumor is found on the right side of the central fibrous body, invading and squeezing the AV node histologically.
  • The lesions are packed by a mucoid  material and are bordered by epithelium, cytokeratin, and epithelial membrane antigen positive.[6]
Hemangioma Histologically characterized by:
  • small capillaries (capillary hemangioma), big vessels (cavernous hemangioma, the most frequent kind), or dysplastic vessels (cirsoid aneurysm).[2]
Hamartoma of Cardiac Myocytes Lesions are defined histologically by a
  • nodular cluster of enlarged, highly disordered cardiomyocytes.[7]
Undifferentiated Pleomorphic Sarcoma Histopathologic features of Undifferentiated Pleomorphic Sarcoma are
  • Typical spindle and polygonal (strap-like) cells filled with an eosinophilic cytoplasm
  • Desmin- and myoglobin-positive
  • CD68 negative[8]
Angiosarcoma Microscopically, angiosarcomas are composed of:
  • Actively growing, invading anaplastic cells originating from blood vessels and lining irregular blood-filled areas and malignant vascular tissue.
  • There are typically extensive areas of bleeding and necrosis inside the tumor.[2]

References

  1. ↑ Maleszewski JJ, Larsen BT, Kip NS, Castonguay MC, Edwards WD, Carney JA; et al. (2014). "PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors". Am J Surg Pathol. 38 (8): 1079–87. doi:10.1097/PAS.0000000000000202. PMID 24618615.
  2. ↑ 2.0 2.1 2.2 2.3 Maleszewski JJ, Anavekar NS, Moynihan TJ, Klarich KW (2017). "Pathology, imaging, and treatment of cardiac tumours". Nat Rev Cardiol. 14 (9): 536–549. doi:10.1038/nrcardio.2017.47. PMID 28436488.
  3. ↑ Lamba G, Frishman WH (2012). "Cardiac and pericardial tumors". Cardiol Rev. 20 (5): 237–52. doi:10.1097/CRD.0b013e31825603e7. PMID 22447042.
  4. ↑ Beghetti M, Gow RM, Haney I, Mawson J, Williams WG, Freedom RM (1997). "Pediatric primary benign cardiac tumors: a 15-year review". Am Heart J. 134 (6): 1107–14. doi:10.1016/s0002-8703(97)70032-2. PMID 9424072.
  5. ↑ Nilsson A, Rasmuson T (2009). "Primary Pericardial Mesothelioma: Report of a Patient and Literature Review". Case Rep Oncol. 2 (2): 125–132. doi:10.1159/000228894. PMC 2918860. PMID 20740175.
  6. ↑ Moorjani N, Kuo J, Wilkins D (2004). "Left atrial phaeochromocytoma". Heart. 90 (11): e64. doi:10.1136/hrt.2004.041319. PMC 1768537. PMID 15486108.
  7. ↑ ElBardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ; et al. (2008). "Analysis of benign ventricular tumors: long-term outcome after resection". J Thorac Cardiovasc Surg. 135 (5): 1061–8. doi:10.1016/j.jtcvs.2007.10.048. PMID 18455585.
  8. ↑ Nakagawa Y, Ikeda U, Hirose M, Ubukata S, Katsuki TA, Kaminishi Y; et al. (2004). "Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab)". Circ J. 68 (2): 172–3. doi:10.1253/circj.68.172. PMID 14745155.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Cardiac_tumors_other_diagnostic_studies&oldid=1727247"